NeuroAiD™II has been awarded Gold accreditation by
independent nonprofit Empowered By Evidence (EBE)
Bringing Innovative Solutions to Healthcare Practitioners
Bringing Innovative Solutions to Healthcare Practitioners.
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries Of The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Shaping the Future of Neurological Care
David Picard, CEO of Moleac, shares insights on unmet needs in post-stroke care and the role of science in improving outcomes for neurological conditions.
Latest News
The Critical Role of Medication Adherence in Preventing Recurrent Stroke: Insights from Real-World Data
Highlights from Moleac at ESOC 2026: Advancing Recovery After Brain Injury
Highlights from Moleac at hashtag#ESOC2026 in Maastricht.
Advancing Neurorehabilitation: Highlights from the Neurological Disorders Summit in Da Nang
This past weekend, Moleac hosted the Advancing Care for Neurological Disorders Summit in Da Nang, Vietnam.
Connecting Global Expertise in Neurorehabilitation: Moleac at ESOC 2026
Advancing Stroke Care Across Asia: Highlights from the 56ᵗʰ ASAP Meeting at ESOC 2026
Thank You, ESOC 2026: Celebrating Connections and Collaboration in Stroke Care
As ESOC draws to a close, we would like to extend a heartfelt thank you to each and every attendee.
Advancing Post-Stroke Recovery: Highlights from Moleac’s ESOC 2026 Symposium
Unlocking Recovery Potential: Advances in Post-Stroke Neurorehabilitation.
Meet Moleac at ESOC 2026 in Maastricht – Visit Us at Booth A55
We are at the European Stroke Organisation Conference in Maastricht!
Join Us Today at ESOC 2026: Unlocking Recovery Potential in Post-Stroke Neurorehabilitation
📢 Join us TODAY at ESOC 2026 in Maastricht. Don’t miss our symposium on Unlocking Recovery Potential: Advances in Post-Stroke Neurorehabilitation.
Expanding Access to Neurorehabilitation: NeuroAiD™II Launches in Mongolia
Moleac is thrilled to announce the successful launch of NeuroAiD™II in Mongolia!
